← All stocks

CytomX Therapeutics, Inc.

CTMX No buying or selling
CIK 0001501989 #2811 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

7 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
McCarthy Sean A.
CEO
2,066,813
$6.30M
+25.6%
BELVIN MARCIA
SVP, Chief Scientific Officer
300,760
$917.32K
+66.5%
Ogden Christopher
Chief Financial Officer
295,324
$900.74K
+173.3%
Chu Yu-Waye
Chief Medical Officer
189,446
$577.81K
+621.7%
ROWLAND LLOYD A
General Counsel
120,594
$367.81K
−7.8%
Carvajal Alejandra
Chief Legal Officer
100,000
$305.00K
Lester Rachael
Chief Business Officer
20,000
$61.00K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 78,258,879 to 217,899,284 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 28 Sep 2016